Problem Statement
With the recent development of new tools, researchers are now able to assess the role of tumor glycans on anti-tumor immunity and immune resistance. Despite its great potential to advance clinical and translational aspects of cancer immunotherapy, there is a marked lack of education and awareness within the field of immuno-oncology on glycobiology and its connection with the immune system, and the field of glyco-immunology remains largely nascent. The scientific community must effectively address and develop the field of glyco-immunology, generating more effective cancer immunotherapies and improving patient outcomes.